- Home
- BSAC vs NBIX Comparison
BSAC vs NBIX Comparison
Compare BSAC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSAC
- NBIX
- Stock Information
- Founded
- BSAC 1977
- NBIX 1992
- Country
- BSAC Chile
- NBIX United States
- Employees
- BSAC N/A
- NBIX N/A
- Industry
- BSAC Commercial Banks
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSAC Finance
- NBIX Health Care
- Exchange
- BSAC Nasdaq
- NBIX Nasdaq
- Market Cap
- BSAC 10.4B
- NBIX 11.0B
- IPO Year
- BSAC 1994
- NBIX 1996
- Fundamental
- Price
- BSAC $23.97
- NBIX $101.38
- Analyst Decision
- BSAC Hold
- NBIX Strong Buy
- Analyst Count
- BSAC 3
- NBIX 21
- Target Price
- BSAC $21.33
- NBIX $163.00
- AVG Volume (30 Days)
- BSAC 496.2K
- NBIX 1.8M
- Earning Date
- BSAC 05-08-2025
- NBIX 05-05-2025
- Dividend Yield
- BSAC 5.64%
- NBIX N/A
- EPS Growth
- BSAC 111.94
- NBIX 33.20
- EPS
- BSAC 0.01
- NBIX 3.29
- Revenue
- BSAC $2,388,377,638.00
- NBIX $2,355,300,000.00
- Revenue This Year
- BSAC $38.24
- NBIX $15.48
- Revenue Next Year
- BSAC $5.96
- NBIX $15.99
- P/E Ratio
- BSAC $10.55
- NBIX $30.81
- Revenue Growth
- BSAC 49.97
- NBIX 24.81
- 52 Week Low
- BSAC $17.73
- NBIX $84.23
- 52 Week High
- BSAC $23.80
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- BSAC 61.34
- NBIX 46.65
- Support Level
- BSAC $20.77
- NBIX $84.23
- Resistance Level
- BSAC $22.48
- NBIX $112.74
- Average True Range (ATR)
- BSAC 0.77
- NBIX 5.17
- MACD
- BSAC 0.11
- NBIX 0.59
- Stochastic Oscillator
- BSAC 97.56
- NBIX 60.45
About BSAC Banco Santander - Chile ADS
Founded in 1978, Banco Santander Chile is part of the Santander group and majority controlled by Santander Spain. Banco Santander is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-sized companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country LATAM Chile.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.